Clinical validation of next-generation sequencing-based clonality assays for minimal residual disease tracking in multiple myeloma

被引:0
|
作者
Lin, Chuanming
Jian, Qijie
Huang, Zoufang
Xie, Shuiling
Xin, Liuyan
Wu, Haiyan
Pang, Fei
Liao, Changfeng
Chen, Yijian
机构
[1] Gannan Med Univ, Affiliated Hosp 1, Ganzhou, Peoples R China
[2] Shanghai OrigiMed Co Ltd, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e20037
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapy
    Yue Huang
    Houli Zhao
    Mi Shao
    Linghui Zhou
    Xiaoqing Li
    Guoqing Wei
    Wenjun Wu
    Jiazhen Cui
    Alex H. Chang
    Tao Sun
    Yongxian Hu
    He Huang
    Bone Marrow Transplantation, 2022, 57 : 1350 - 1353
  • [32] Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms
    Liu, Ying
    Ho, Caleb
    Yu, Wayne
    Huang, Ying
    Miller, Jeffrey
    Gao, Qi
    Syed, Mustafa
    Ma, Yuanyuan
    Wang, Meiyi
    Maciag, Lidia
    Petrova-Drus, Kseniya
    Zhu, Menglei
    Yao, JinJuan
    Vanderbilt, Chad
    Durham, Benjamin
    Benhamida, Jamal
    Ewalt, Mark D.
    Dogan, Ahmet
    Roshal, Mikhail
    Nafa, Khedoudja
    Arcilat, Maria E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (03): : 168 - 178
  • [33] Library Pooling of Multiple Assays for Clinical Next-Generation Sequencing
    Wu, X.
    Tu, Z.
    Peterson, L. M.
    Dukek, B. A.
    Blommel, J. H.
    Henke, S. A.
    Thompson, W. C.
    Klee, E. W.
    Ferber, M. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 707 - 707
  • [34] A Novel Approach to Next-Generation Sequencing-Based Assessment of T-cell Clonality
    Oldridge, D. A.
    Gentile, C.
    Rosenbaum, J. N.
    Van Deerlin, V. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1245 - 1246
  • [35] A Comparison Between Next-Generation Sequencing and ASO-qPCR For Minimal Residual Disease Detection In Multiple Myeloma: The Clinical Value In ASCT Setting
    Takamatsu, Hiroyuki
    Mura, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Yasushi, Terasaki
    Takashi, Yoshida
    Faham, Malek
    Nakao, Shinji
    BLOOD, 2013, 122 (21)
  • [36] A COMPARISON BETWEEN NEXT-GENERATION SEQUENCING AND ASO-QPCR FOR MINIMAL RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA: THE CLINICAL VALUE IN ASCT SETTING
    Takamatsu, H.
    Murata, R.
    Ito, S.
    Zheng, J.
    Moorhead, M.
    Terasaki, Y.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    HAEMATOLOGICA, 2014, 99 : 113 - 114
  • [37] Analytical Validation of a Next-Generation Sequencing Assay for Detecting Minimal Residual Disease in Lymphoid Malignancies
    Zhou, Yiwei
    Ma, Zhiyuan
    Huang, Shiang
    Li, Zhenhui
    Lei, Beining
    Zou, Fang
    Li, Qijiao
    Liang, Liang
    Sun, Li
    Zhang, Jie
    BLOOD, 2024, 144 : 4972 - 4973
  • [38] Multiple Immunoglobulin κ Gene Rearrangements within a Single Clone Unraveled by Next-Generation Sequencing-Based Clonality Assessment
    Leenders, A. Meilinde
    Kroeze, Leonie I.
    Rijntjes, Jos
    Luijks, Jeroen
    Hebeda, Konnie M.
    Darzentas, Nikos
    Langerak, Anton W.
    van den Brand, Michiel
    Groenen, Patricia J. T. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (09): : 1097 - 1104
  • [39] Validation of a PCR-Based Next-Generation Sequencing Approach for the Detection and Quantification of Minimal Residual Disease in Acute Lymphoblastic Leukemia and Multiple Myeloma Using gBlocks as Calibrators
    Van der Straeten, Jona
    De Brouwer, Wouter
    Kabongo, Emmanuelle
    Dresse, Marie-Francoise
    Fostier, Karel
    Schots, Rik
    Van Riet, Ivan
    Bakkus, Marleen
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (05): : 599 - 611
  • [40] Cost-effectiveness of next-generation sequencing minimal residual disease testing during maintenance treatment for multiple myeloma.
    Carlson, Josh John
    Eckert, Benjamin
    Zimmerman, Marita
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)